« Back to old times? | Main | Feds probe Delphi exec »

October 04, 2005

Citigroup memo suggests concern

Citigroup memo suggests concern over research 
CBS Market Watch - Sep 08 12:47 PM
NEW YORK (MarketWatch) - A Citigroup memo from 2002 suggests there was internal debate about the company's stock research being tainted by the pursuit of investment banking fees.

Cell Therapeutics shares get boost from Xyotax results 
Seattle Times - Oct 01 1:10 AM
Cell Therapeutics' battered shares climbed nearly 37 percent yesterday after Chief Executive James Bianco announced additional data showing...

Drug giant Glaxo buying ID Biomedical for vaccines 
Seattle Times - Sep 21 1:11 AM
Id biomedical, a Canadian vaccine maker with 100 employees in Bothell, has agreed to be acquired by pharmaceutical giant GlaxoSmithKline...

Steffy: Analyst hits a nerve at Cyberonics 
Houston Chronicle - Oct 01 10:46 PM
CYBERONICS is not happy with Alex Arrow, but investors should be. Arrow is an analyst with New York-based Lazard Capital Markets, and at the moment, he thinks shares of the Houston medical device maker are overvalued.

Posted by auctionbullet at October 4, 2005 03:46 AM